(Q46529511)

22 December 2017

title

18FDG-PET applications for cartilage neoplasms (English)

1 reference

22 December 2017

1 reference

Frieda Feldman

1

1 reference

22 December 2017

Ronald Van Heertum

series ordinal

2

1 reference

22 December 2017

Chitra Saxena

series ordinal

3

1 reference

22 December 2017

May Parisien

series ordinal

4

1 reference

22 December 2017

publication date

4 June 2005

1 reference

22 December 2017

published in

Skeletal Radiology

1 reference

22 December 2017

volume

34

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

367-374

1 reference

22 December 2017

18FDG PET scanning of benign and malignant musculoskeletal lesions

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00256-005-0894-Y

FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-005-0894-Y

Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-005-0894-Y

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00256-005-0894-Y

Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

12 December 2020

Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading

1 reference

12 December 2020

Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET

1 reference

12 December 2020

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution

1 reference

12 December 2020

FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging

1 reference

12 December 2020

Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis

1 reference

12 December 2020

Low-grade chondrosarcomas: a difficult target for radionuclide imaging. Case report and review of the literature

1 reference

12 December 2020

Chondrosarcoma: correlation of radiological and histological grade

1 reference

12 December 2020

A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection

1 reference

12 December 2020

Metabolic imaging of human extremity musculoskeletal tumors by PET.

1 reference

12 December 2020

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography

1 reference

12 December 2020

FDG-PET in differential diagnosis and grading of chondrosarcomas

1 reference

12 December 2020

Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors

1 reference

12 December 2020

Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms?

1 reference

12 December 2020

Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma

1 reference

12 December 2020

The role of positron emission tomography in skeletal disease.

1 reference

12 December 2020

The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors

1 reference

12 December 2020

FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients

1 reference

12 December 2020

Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings

1 reference

12 December 2020

10.1007/S00256-005-0894-Y

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017